Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen. (Q43143675)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

acute myeloid leukemia

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Phillip K. Darcy

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Paul Neeson

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Joseph A. Trapani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Simon Harrison

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Andrew M Scott

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

10

F E Smyth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

S Peinert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

H M Prince

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

P M Guru

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

P Gambell

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

K Tainton

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

D S Ritchie

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

D Hönemann

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

M J Smyth

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

4 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

678-686

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20200563%20AND%20SRC:MED&resulttype=core&format=json

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

A comparison of allografting with autografting for newly diagnosed myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Redirecting T lymphocyte specificity by T cell receptor gene transfer--a new era for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Inhibition of bispecific monoclonal antibody (bsAb)-targeted cytolysis by human anti-mouse antibodies in ovarian carcinoma patients treated with bsAb-targeted activated T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Rejection of Syngeneic Colon Carcinoma by CTLs Expressing Single-Chain Antibody Receptors Codelivering CD28 Costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

The fucosylated histo-blood group antigens H type 2 (blood group O, CD173) and Lewis Y (CD174) are expressed on CD34+ hematopoietic progenitors but absent on mature lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Immunotherapy of multiple myeloma: the start of a long and tortuous journey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

The development of novel immunotherapeutic approaches in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Generation of anti-idiotype antibodies for application in clinical immunotherapy laboratory analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Immunotherapy of cancer using systemically delivered gene-modified human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

7 January 2021

Serological and immunochemical analysis of Lewis y (Ley) blood group antigen expression in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

7 January 2021

Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

7 January 2021

Correlation of Expression of H/LeY/LeBAntigens with Survival in Patients with Carcinoma of the Lung

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

7 January 2021

Phase I trial of the anti-Lewis Y drug immunoconjugate BR96-doxorubicin in patients with lewis Y-expressing epithelial tumors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.21

7 January 2021